CD4-directed Blocking Antibody [EPC] - N0000193806

Pharmacologic Class Information

Pharmacologic Code N0000193806
Pharmacologic Name CD4-directed Blocking Antibody
Pharmacologic Uses
  • CD4-directed post-attachment HIV-1 inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with CD4-directed Blocking Antibody

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD4-directed Blocking Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
62064-122Trogarzo Non-Proprietary Name: IbalizumabInjection, SolutionIntravenousTheratechnologies Inc.ACTIVE